| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥184.95B | ¥180.17B | +2.7% |
| Cost of Sales | ¥101.25B | ¥96.49B | +4.9% |
| Gross Profit | ¥83.69B | ¥83.68B | +0.0% |
| SG&A Expenses | ¥78.48B | ¥77.30B | +1.5% |
| Operating Income | ¥5.22B | ¥6.38B | -18.3% |
| Non-operating Income | ¥1.06B | ¥962M | +9.8% |
| Non-operating Expenses | ¥3.17B | ¥2.27B | +39.8% |
| Ordinary Income | ¥3.11B | ¥5.08B | -38.9% |
| Profit Before Tax | ¥3.11B | ¥10.56B | -70.6% |
| Income Tax Expense | ¥2.94B | ¥3.23B | -9.1% |
| Net Income | ¥171M | ¥7.33B | -97.7% |
| Net Income Attributable to Owners | ¥468M | ¥7.23B | -93.5% |
| Total Comprehensive Income | ¥1.79B | ¥4.09B | -56.1% |
| Interest Expense | ¥753M | ¥657M | +14.6% |
| Basic EPS | ¥14.80 | ¥229.27 | -93.5% |
| Dividend Per Share | ¥15.00 | ¥15.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥97.43B | ¥92.04B | +¥5.38B |
| Cash and Deposits | ¥26.73B | ¥30.66B | ¥-3.93B |
| Accounts Receivable | ¥34.21B | ¥26.39B | +¥7.82B |
| Inventories | ¥11.39B | ¥11.04B | +¥344M |
| Non-current Assets | ¥95.24B | ¥93.20B | +¥2.04B |
| Item | Value |
|---|---|
| Net Profit Margin | 0.3% |
| Gross Profit Margin | 45.3% |
| Current Ratio | 173.0% |
| Quick Ratio | 152.8% |
| Debt-to-Equity Ratio | 1.04x |
| Interest Coverage Ratio | 6.93x |
| Effective Tax Rate | 94.5% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +2.7% |
| Operating Income YoY Change | -18.3% |
| Ordinary Income YoY Change | -38.8% |
| Net Income Attributable to Owners YoY Change | -93.5% |
| Total Comprehensive Income YoY Change | -56.1% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 33.14M shares |
| Treasury Stock | 1.44M shares |
| Average Shares Outstanding | 31.64M shares |
| Book Value Per Share | ¥2,973.72 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥15.00 |
| Year-End Dividend | ¥25.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| DomesticBeverage | ¥110.21B | ¥-1.21B |
| DyDoPharma | ¥396M | ¥-274M |
| Food | ¥16.01B | ¥772M |
| InternationalBeverage | ¥48.34B | ¥6.09B |
| PharmaceuticalRelated | ¥10.30B | ¥726M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥243.40B |
| Operating Income Forecast | ¥1.80B |
| Ordinary Income Forecast | ¥-400M |
| Net Income Attributable to Owners Forecast | ¥-3.00B |
| Basic EPS Forecast | ¥-94.84 |
| Dividend Per Share Forecast | ¥15.00 |
| Property, Plant & Equipment | ¥61.88B | ¥59.95B | +¥1.93B |
| Intangible Assets | ¥11.40B | ¥11.87B | ¥-462M |
| Goodwill | ¥5.03B | ¥5.41B | ¥-372M |
| Investment Securities | ¥11.09B | ¥9.81B | +¥1.27B |
| Total Assets | ¥192.67B | ¥185.25B | +¥7.42B |
| Current Liabilities | ¥56.32B | ¥63.55B | ¥-7.23B |
| Accounts Payable | ¥29.18B | ¥25.17B | +¥4.01B |
| Short-term Loans | ¥8M | - | - |
| Non-current Liabilities | ¥42.09B | ¥28.19B | +¥13.89B |
| Long-term Loans | ¥15.60B | ¥6.96B | +¥8.63B |
| Total Liabilities | ¥98.41B | ¥91.74B | +¥6.67B |
| Total Equity | ¥94.26B | ¥93.51B | +¥757M |
| Capital Stock | ¥1.92B | ¥1.92B | ¥0 |
| Capital Surplus | ¥1.87B | ¥1.87B | ¥0 |
| Retained Earnings | ¥92.23B | ¥93.04B | ¥-805M |
| Treasury Stock | ¥-3.28B | ¥-3.52B | +¥238M |
| Owners' Equity | ¥92.95B | ¥91.91B | +¥1.03B |
| Working Capital | ¥41.11B | - | - |